EUVIMEDEUVIMED entdecken
Crossref

DOX encapsulated silica@alginate/PVA nanocomposite films for osteosarcoma

Yuming Bai, Qinghai Wang, Shengli Jin, Keting Jin, Han Qi, Mahani Yusoff, Alina Irwana Muhamad A’srai, Mohd Hasmizam Razali

Green Materials · 12.05.2026 · 1-11

DOI: 10.1680/jgrma.26.00005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Green Materials, online erschienen am 12.05.2026. Verfasst von Yuming Bai und 7 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Gefördert von: 2024 Medical Science Research Project Plan of Hebei Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma remains a highly aggressive bone malignancy with limited therapeutic outcomes due to systemic toxicity and multidrug resistance associated with conventional doxorubicin (DOX) chemotherapy. To address these challenges, this study reports the development of a novel localised drug delivery platform comprising DOX-encapsulated amorphous silica nanoparticles (aSNs) embedded in sodium alginate (SA) and polyvinyl alcohol (PVA) nanocomposite films. aSNs were synthesised via sol–gel methods and characterised for their drug loading efficiency, achieving 95.3 ± 2.01% encapsulation. These nanoparticles were integrated into PVA/SA films to fabricate aSNs@SA + PVA nanocomposite films, followed by comprehensive characterisation using SEM, Fourier transform infra-red spectroscopy, swelling, porosity, thermal analysis, and biodegradation studies. The optimised 10 Wt.% aSNs@SA + PVA nanocomposite film exhibited desirable swelling (85.9%), high porosity (90.28%), and moderate biodegradation (50.99%), supporting its suitability for localised therapeutic applications for bone tissue regeneration. In vitro drug release showed sustained and pH-responsive behaviour, with significantly enhanced DOX release under acidic tumour-mimicking conditions (pH 5.5) compared with physiological pH (7.4). Cell viability assessment using MG-63 cells demonstrated potent cell proliferation efficacy, comparable with tissue culture polystyrene plate control after 24 h. These results indicate that the aSNs@SA + PVA nanocomposite film offers a promising strategy for osteosarcoma treatment and reduced systemic toxicity.

Förderung

  • 2024 Medical Science Research Project Plan of Hebei Province

Zitieren

APA

Bai, Y., Wang, Q., Jin, S., Jin, K., Qi, H., Yusoff, M., A’srai, A. I. M., & Razali, M. H. (2026). DOX encapsulated silica@alginate/PVA nanocomposite films for osteosarcoma. Green Materials, 1-11. https://doi.org/10.1680/jgrma.26.00005

Vancouver

Bai Y, Wang Q, Jin S, Jin K, Qi H, Yusoff M, et al. DOX encapsulated silica@alginate/PVA nanocomposite films for osteosarcoma. Green Materials. 2026:1-11. doi:10.1680/jgrma.26.00005

BibTeX
@article{Bai2026,
  author = {Bai, Yuming and Wang, Qinghai and Jin, Shengli and Jin, Keting and Qi, Han and Yusoff, Mahani and A’srai, Alina Irwana Muhamad and Razali, Mohd Hasmizam},
  title = {DOX encapsulated silica@alginate/PVA nanocomposite films for osteosarcoma},
  journal = {Green Materials},
  year = {2026},
  pages = {1--11},
  doi = {10.1680/jgrma.26.00005}
}
Kostenlos starten →